Actualités sur Enterprises
- Langue:
- Médias:
- Période:
- Période:Totale
- 2plus
DEBIOPHARM AND GENOME & COMPANY JOIN FORCES TO CREATE NEW HIGHLY SPECIFIC THERAPIES FOR CANCER PATIENTS
Lausanne, Switzerland and Seongnam-si Gyeonggi-do, Republic of Korea (ots) - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (314130, CEO: Jisoo Pae, Hansoo Park), a global leading ...
plusMartin Bosshardt Appointed New Anapaya CEO / Bosshardt's 20 years of networking and security experience is expected to lead the company into 2021
plusNUCLEAI AND DEBIOPHARM LAUNCH RESEARCH COLLABORATION UTILIZING NUCLEAI’S AI-POWERED BIOMARKER PLATFORM
Tel Aviv, Israel / Lausanne, Switzerland (ots) - Nucleai (www.Nucleaimd.com), a global provider in pathology-based biomarker discovery, and Debiopharm (www.debiopharm.com), a Swiss-based biopharmaceutical company specializing in drug development, announced that they have entered into a long-term collaboration to ...
plusHostpoint now offers protection against domain loss
plus- 3
Max Lehner AG (MAXOLEN) Switzerland and DEGAMA Srl (AUTOEQUIP LAVAGGI) Italia agree an exclusive partnership for the distribution and provision of washing systems in Switzerland.
plus
- 2
Global Retailer group OYSHO and Swiss apparel technology group X-BIONIC & X-SOCKS design a collection together / OYSHO by X-BIONIC I Once again, Fashion follows function
plus New model of corporate governance at Ricola
Laufen (ots) - Ricola separates the strategic and operational management of the company. As of January 2021, the members of the family owning the company will focus on their tasks in the Boards of Directors of Ricola Group Ltd. and the parent company Ricola Family Holding Ltd., leaving the operational management of the company to leaders from outside the family headed by CEO Thomas P. Meier. Eva Richterich, currently Head ...
plusRoche teams up with Diabeloop to advance the management of insulin pump therapy
Basel (ots) - - The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes(1). - By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche's strategy of integrated Personalised Diabetes Management (iPDM). Roche ...
plusLodbrok Capital issues letter to Aryzta Board on AGM and decision on offer from Elliott Advisors (UK)
LONDON (ots) - Lodbrok Capital has today issued a letter to the Board of Aryzta in relation to binding offer from Elliott Advisors (UK) Limited ("Elliott") for the entire share capital of Aryzta at a price of 0.80 CHF per share. The letter makes clear our position that it would be highly inappropriate and grossly ...
plusEMD - European Marketing Distribution
EMD: Eric Lemercier appointed director Business Development
plusswissstaffing - Verband der Personaldienstleister der Schweiz
Swiss Staffingindex - A Second Wave of Coronavirus Threatens the Swiss Labor Market
Un documentplus
Hostpoint now supports DNSSEC and DANE
plusFashion brand TOM TAILOR lays foundations for further enhancing its successful positioning in the casual lifestyle segment
Hamburg (ots) - - Tom Tailor GmbH (TOM TAILOR) retains its long-term strategic investor with extensive industry experience following its complete takeover by Fosun International Limited - Based on the milestones it has already achieved, TOM TAILOR will implement its development plan by taking specific strategic and ...
plusDEBIOPHARM HONORED AS A 2020 SWISS BIOTECH SUCCESS STORY WINNER FOR OUTSTANDING ACHIEVEMENTS OVER 40 YEARS
Lausanne, Switzerland (ots) - Debiopharm, (www.debiopharm.com), a Swiss-based biopharmaceutical company today announced being one of the recipients of the 2020 Swiss Biotech Success Story Award for exceptional achievements in the biotech industry. Every year, the Swiss Biotech Association awards companies or ...
plusDEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS
Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ...
Un documentplusSynova substantially limits the Swiss part of EP 1833636 B1 as granted before the Swiss Federal Institute of Intellectual Property
Zug (ots) - Following substantial evidence brought up against the validity of Synova's EP 1833636 B1 by Avonisys AG in ongoing court proceedings before the Swiss Federal Patent Court, Synova substantially limited the original patent on 14 August 2020 by means of limitation proceedings before the Swiss Federal ...
plusMSD (Merck Sharp & Dohme AG) Switzerland appoints Ans Heirman, Ph.D. as the new Managing Director of MSD Switzerland, effective September 1st, 2020
Un documentplus
Net profit increases 28% to CHF 537 million in the first half of 2020
Zurich (ots) - - Outstanding result for first half of 2020 underscores bank's solid business model - Increased operating income of CHF 1,310 million (+12.4%), with positive results across all income drivers - Significantly lower cost/income ratio of 55.2% - Excellent net inflow of new money totalling CHF ...
Un documentplusThe Future of Real Estate: Sustainable Construction Innovation
Stuttgart (ots) - How are market leaders answering to the current sustainability challenges? Which sustainability goals did they set themselves? Which strategies have they put in place to achieve those goals? We will discuss these and other important questions in our free virtual Strybinar. Learn from successful industry leaders and innovators within the DACH market on ...
plusQCAM Currency Asset Management AG
With three new additions to the Board of Directors, QCAM Currency Asset Management AG underpins its leading position in Asset and Currency Management
plusVersameb raises CHF 6 million and strengthens team to advance its VERSagile technology platform towards clinical trials
Basel, Switzerland (ots) - Versameb AG, a biopharmaceutical company developing innovative ribonucleic acid (RNA) therapeutics, announced today the closing of a CHF 6 million seed financing round. Versameb further strengthens its team by the appointment of Dr. Klaas P. Zuideveld as Chief Development Officer effective ...
plusDr. Philipp Roesler Joins the Brainloop AG Supervisory Board
plusPositive development of Ricola in 2019
Laufen (ots) - Ricola looks back on a good business year 2019 with pleasing growth in various export markets and successful launches of new products. 2019 was also a year of change for the traditional family-owned Swiss company. In May 2019, Thomas P. Meier took over the responsibility as CEO from Felix Richterich, who has since been focusing on his strategic role as Chairman of the Board of Directors. "Multi-Active" and ...
plus
Acquisition of Debiopharm's investment portfolio company Kaiku Health broadens patient access to digital oncology intervention
Lausanne, Switzerland (ots) - - Debiopharm announces successful exit deal for Kaiku Health, a Finnish start-up specializing in digital solutions for improved patient outcomes and experience - Kaiku's acquisition by the Swedish company Elekta allows thousands of cancer treatment centers to gain access to the ...
plus- 2
Haut Chocolatier Sprüngli presents its new Grand Cru Absolu chocolate
plus Positive operating result for SIFEM in 2019 - and uncertain outlook for 2020 due to the COVID-19 crisis
Bern (ots) - In 2019, the Swiss Investment Fund for Emerging Markets (SIFEM) committed a total of USD 104.5 million across nine different projects and concluded the year with a positive operating result of CHF 5.1 million. However, the outlook for SIFEM's portfolio in 2020 has taken a sudden negative turn in the ...
plusswissstaffing - Verband der Personaldienstleister der Schweiz
2Swiss Staffingindex - The Crunch of the Corona-minus: 12% Slump in March
Un documentplusTextile entrepreneur produces masks for individuals, freelancers and companies
plus- 2
TripAdvisor accuses Swiss startup TWISPER of unfair competition
plus